-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Merck & Co, Raises Price Target to $170

Benzinga·09/04/2026 14:27:52
Listen to the news
Wells Fargo analyst Mohit Bansal maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $150 to $170.